TH1501001422A - Pyrazolecarboxamide derivatives as TAAR modulators for therapeutic use Many disorders such as depression, diabetes, and Parkinson's disease - Google Patents

Pyrazolecarboxamide derivatives as TAAR modulators for therapeutic use Many disorders such as depression, diabetes, and Parkinson's disease

Info

Publication number
TH1501001422A
TH1501001422A TH1501001422A TH1501001422A TH1501001422A TH 1501001422 A TH1501001422 A TH 1501001422A TH 1501001422 A TH1501001422 A TH 1501001422A TH 1501001422 A TH1501001422 A TH 1501001422A TH 1501001422 A TH1501001422 A TH 1501001422A
Authority
TH
Thailand
Prior art keywords
parkinson
diabetes
depression
disease
therapeutic use
Prior art date
Application number
TH1501001422A
Other languages
Thai (th)
Other versions
TH156898A (en
Inventor
แกลลีย์นายโรเจอร์ นอร์ครอสส์นายฟิลิปป์ ฟลีเกอร์ นายกุยโด
Original Assignee
เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี
Filing date
Publication date
Application filed by เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี filed Critical เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี
Publication of TH1501001422A publication Critical patent/TH1501001422A/en
Publication of TH156898A publication Critical patent/TH156898A/en

Links

TH1501001422A 2013-09-11 Pyrazole carboxamide derivative as a TAAR modulator for therapeutic use. Many disorders, such as depression, diabetes and Parkinson's disease. TH156898A (en)

Publications (2)

Publication Number Publication Date
TH1501001422A true TH1501001422A (en) 2016-09-30
TH156898A TH156898A (en) 2016-09-30

Family

ID=

Similar Documents

Publication Publication Date Title
PL2968218T3 (en) Combination for the treatment of parkinson's disease
HK1219943A1 (en) Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders 3-
BR302012004627S1 (en) "STANDARD APPLIED TO GRAPHIC USER INTERFACE FOR A DISPLAY OR PART OF THE SAME"
LTPA2020511I1 (en) Cyclesonide for the treatment of respiratory diseases in horses
EP2820013A4 (en) Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions
EP2990040A4 (en) Therapeutic agent for eyeground disease
ES2627541T8 (en) Methods to treat Parkinson's disease
CL2015002933A1 (en) Identification of the patient's response to the administration of a s1p receptor modulator.
HK1216641A1 (en) 1,2,3-triazole-4-amine derivatives for the treatment of sigma receptor related diseases and disorders 123--4-
HK1206720A1 (en) Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinsons disease taar
EP3086846A4 (en) Diagnosing and treating alzheimer's disease
BR112015009088A2 (en) levodopa formulations for rapid relief of parkinson's disease.
IL274203A (en) Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
HK1216154A1 (en) Drug delivery device for peripheral artery disease
CL2015001520A1 (en) Slurp-1 protein for use in the treatment of eye diseases
EP2968222A4 (en) Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
TH1501001422A (en) Pyrazolecarboxamide derivatives as TAAR modulators for therapeutic use Many disorders such as depression, diabetes, and Parkinson's disease
IL260009B (en) Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease
DOP2015000290A (en) BENZOXAZOLES REPLACED
IL241397A0 (en) Methods, compositions and devices for treatment of motor and depression symptoms associated with parkinson's disease
BR112016029044A2 (en) 2- (2-methylamino-pyrimidin-4-yl) -1h-indol-5-carboxylic acid [(s) -1-carbamoyl-2- (phenyl-pyrimidin-2-yl-amino) -ethyl] - amide for use in the treatment of osteoarthritis pain
TH1401006421A (en) Compounds for use in the manufacture of drugs for the treatment of steroid-responsive skin diseases.
MA35119B1 (en) Medication to treat diabetes
UA24322S (en) THE BEE-KEEPER'S STAMP
ITTO20130099U1 (en) ELASTIC BANDAGE, PARTICULARLY FOR USE IN THE TREATMENT OF THE VENO-LYMPHATIC INSTRUCTIVE EDEMA